BioMarin Pharmaceutical Inc. has grown revenue 14% a year over three years and 12% a year over five, with earnings per share compounding at 53%. Revenue growth, 3-year annual rate: +14% (Biotechnology median +21%). Revenue growth, 5-year rate: +12%, growth has picked up over the last three years. Earnings per share, 3-year rate: +53%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

BMRNBioMarin Pharmaceutical Inc.

HealthcareUSD

$65.62

$49.6752 weeks$70.23

Is it growing?

Is BMRN growing?

BioMarin Pharmaceutical Inc. has grown revenue 14% a year over three years and 12% a year over five, with earnings per share compounding at 53%.

+14%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +12%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +53%
Earnings per share, 3-year rate · revenue +14% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed